HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease

Clinical trial NCT00243724 · COMPLETED

Trial details

NCT number: NCT00243724
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroesophageal Reflux Heartburn Dyspepsia

Start date: 2005-04-01
Primary completion: 2007-06-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.